PARIS & EASTLEIGH, England (BUSINESS WIRE) Regulatory News:Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s genesig® COVID-19 3G Real-Time PCR test has been approved in the UK under the UK Health Security Agency's Medical Devices (Corona.
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's genesig COVID-19 3G Real-Time PCR test has been approved